Kanagawa, Japan

Kazuyuki Ojima

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuyuki Ojima. Retrieved from https://idiyas.com/inventor/kazuyuki-ojima-3gb11o3o

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuyuki Ojima: Innovator in Immunology

Introduction

Kazuyuki Ojima is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of immunology, particularly through his research on natural killer (NK) cells. His work has implications for understanding immune responses and developing therapeutic strategies.

Latest Patents

Kazuyuki Ojima holds a patent related to proteins expressed in NK cells. His patent focuses on the identification of the NKIR gene, which is specifically expressed in natural killer cells. This gene encodes a receptor that can be targeted by agonists and antagonists, providing a pathway for further research and potential treatments.

Career Highlights

Ojima is associated with Chugai Seiyaku Kabushiki Kaisha, a prominent pharmaceutical company in Japan. His role at the company has allowed him to engage in cutting-edge research and development in the field of immunology. His work has contributed to advancements in understanding immune cell functions and their applications in medicine.

Collaborations

Throughout his career, Kazuyuki Ojima has collaborated with esteemed colleagues, including Kouji Matsushima and Shinichi Hashimoto. These collaborations have fostered a productive research environment, leading to innovative discoveries in the field.

Conclusion

Kazuyuki Ojima's contributions to immunology through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic strategies targeting immune responses.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…